Additional information
White Amorphous Powder
50910-53-7
ACI-010603
trans-4-[[(E)-2-amino-3,5-dibromobenzyliden]amino]cyclohexanol
trans-4-[[(E)-2-amino-3,5-dibromobenzyliden]amino]cyclohexanol
115.4-117.8°C
C13H16Br2N2O
376.09
Ambient
2-8°C
Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methylene]amino]-, trans
Mucolytic
Pharmaceutical Impurity Standards





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)